These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 20160967)

  • 1. In vitro models of pancreatic cancer for translational oncology research.
    Feldmann G; Rauenzahn S; Maitra A
    Expert Opin Drug Discov; 2009 Apr; 4(4):429-443. PubMed ID: 20160967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent developments of transgenic and xenograft mouse models of pancreatic cancer for translational research.
    Schütte U; Bisht S; Brossart P; Feldmann G
    Expert Opin Drug Discov; 2011 Jan; 6(1):33-48. PubMed ID: 22646825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SCNrank: spectral clustering for network-based ranking to reveal potential drug targets and its application in pancreatic ductal adenocarcinoma.
    Liu E; Zhang ZZ; Cheng X; Liu X; Cheng L
    BMC Med Genomics; 2020 Apr; 13(Suppl 5):50. PubMed ID: 32241274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Animal models for modeling pancreatic cancer and novel drug discovery.
    Bisht S; Feldmann G
    Expert Opin Drug Discov; 2019 Feb; 14(2):127-142. PubMed ID: 30657339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics of pancreatic ductal adenocarcinomas and recent implications for translational efforts.
    Feldmann G; Maitra A
    J Mol Diagn; 2008 Mar; 10(2):111-22. PubMed ID: 18258927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translational genomics in pancreatic ductal adenocarcinoma: A review with re-analysis of TCGA dataset.
    Ho J; Li X; Zhang L; Liang Y; Hu W; Yau JCW; Chan H; Gin T; Chan MTV; Tse G; Wu WKK
    Semin Cancer Biol; 2019 Apr; 55():70-77. PubMed ID: 29705685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding pancreatic cancer genomes.
    Cowley MJ; Chang DK; Pajic M; Johns AL; Waddell N; Grimmond SM; Biankin AV
    J Hepatobiliary Pancreat Sci; 2013 Aug; 20(6):549-56. PubMed ID: 23660961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinase signaling pathways as targets for intervention in pancreatic cancer.
    Preis M; Korc M
    Cancer Biol Ther; 2010 May; 9(10):754-63. PubMed ID: 20234186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic Progenitors and Organoids as a Prerequisite to Model Pancreatic Diseases and Cancer.
    Hohwieler M; Müller M; Frappart PO; Heller S
    Stem Cells Int; 2019; 2019():9301382. PubMed ID: 30930950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future.
    Christenson ES; Jaffee E; Azad NS
    Lancet Oncol; 2020 Mar; 21(3):e135-e145. PubMed ID: 32135117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic strategies in the search for novel pancreatic cancer biomarkers and drug targets: recent advances and clinical impact.
    Coleman O; Henry M; McVey G; Clynes M; Moriarty M; Meleady P
    Expert Rev Proteomics; 2016; 13(4):383-94. PubMed ID: 26985644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Evolving Understanding of the Molecular and Therapeutic Landscape of Pancreatic Ductal Adenocarcinoma.
    Parkin A; Man J; Chou A; Nagrial AM; Samra J; Gill AJ; Timpson P; Pajic M
    Diseases; 2018 Nov; 6(4):. PubMed ID: 30428574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetically engineered mouse models of pancreatic cancer: unravelling tumour biology and progressing translational oncology.
    Mazur PK; Siveke JT
    Gut; 2012 Oct; 61(10):1488-500. PubMed ID: 21873467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Managing Pancreatic Adenocarcinoma: A Special Focus in MicroRNA Gene Therapy.
    Passadouro M; Faneca H
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Targets in Pancreatic Cancer Therapy - Current Status and Ongoing Translational Efforts.
    Bisht S; Feldmann G
    Oncol Res Treat; 2018; 41(10):596-602. PubMed ID: 30269126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New tools for old drugs: Functional genetic screens to optimize current chemotherapy.
    Gerhards NM; Rottenberg S
    Drug Resist Updat; 2018 Jan; 36():30-46. PubMed ID: 29499836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging drugs for the treatment of pancreatic cancer.
    Van Laethem JL; Marechal R
    Expert Opin Emerg Drugs; 2007 May; 12(2):301-11. PubMed ID: 17604503
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.